The National Academies of Sciences, Engineering, and Medicine Committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute Pain will host a Feb. 4 public workshop as part of its information gathering activities. The Food and Drug Administration last year awarded NASEM a contract to develop evidence-based guidelines for appropriate opioid prescribing for acute pain. The workshop will feature presentations and panel discussions on surgical procedures and medical conditions associated with acute pain, and identifying and using evidence to inform the guidelines. To attend the workshop in person or via webcast, register here. AHA is a member of the National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, a public-private partnership that will develop and disseminate evidence-based solutions to reduce opioid misuse and improve outcomes for individuals, families and communities affected by addiction.
 

Related News Articles

Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…